BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes (BESTMED)
Sponsor: Allina Health
A observational or N/A phase clinical study on Diabetes Mellitus, Type 2, this trial is ongoing. The trial is conducted by Allina Health and has accumulated 5 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Jul 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Jul 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2023 — Jul 2024 [monthly]
Recruiting
-
Jan 2022 — Jul 2023 [monthly]
Recruiting
First recorded
Jul 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Allina Health
- Baylor College of Medicine
- Baylor Scott and White Research Institute
- Brigham and Women's Hospital
- HealthCore, Inc.
- Humana Inc.
- Intermountain Health Care, Inc.
- Marshfield Clinic
- Massachusetts General Hospital
- Medical College of Wisconsin
- Medical Outcomes Management
- Patient-Centered Outcomes Research Institute
- The Cleveland Clinic
- University of Iowa
- University of Missouri-Columbia
- University of Utah
For direct contact, visit the study record on ClinicalTrials.gov .